Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1953 1
1958 2
1962 1
1963 4
1964 8
1965 6
1969 1
1971 2
1975 4
1976 5
1977 3
1978 1
1979 5
1980 6
1981 4
1982 3
1983 7
1984 4
1985 5
1986 7
1987 13
1988 14
1989 15
1990 25
1991 27
1992 27
1993 29
1994 21
1995 38
1996 33
1997 37
1998 51
1999 45
2000 64
2001 43
2002 50
2003 72
2004 81
2005 85
2006 98
2007 102
2008 138
2009 145
2010 172
2011 181
2012 209
2013 217
2014 212
2015 189
2016 179
2017 143
2018 191
2019 157
2020 166
2021 166
2022 133
2023 103
2024 64

Text availability

Article attribute

Article type

Publication date

Search Results

3,389 results

Results by year

Filters applied: . Clear all
Page 1
Glioblastoma Multiforme, Diagnosis and Treatment; Recent Literature Review.
Batash R, Asna N, Schaffer P, Francis N, Schaffer M. Batash R, et al. Curr Med Chem. 2017;24(27):3002-3009. doi: 10.2174/0929867324666170516123206. Curr Med Chem. 2017. PMID: 28521700 Review.
BACKGROUND: Glioblastoma multiforme (GBM) is the most common malignant primary brain tumor, with an incidence of 3.19 cases per 100,000 person years and remarkably poor prognosis showing a 5-year survival rate of 4-5%, and only a 26-33% survival rate at 2 years in c …
BACKGROUND: Glioblastoma multiforme (GBM) is the most common malignant primary brain tumor, with an incidence of 3.19 cases pe …
Emerging treatment strategies for glioblastoma multiforme.
Carlsson SK, Brothers SP, Wahlestedt C. Carlsson SK, et al. EMBO Mol Med. 2014 Nov;6(11):1359-70. doi: 10.15252/emmm.201302627. EMBO Mol Med. 2014. PMID: 25312641 Free PMC article. Review.
Glioblastoma multiforme (GBM) is the deadliest form of brain tumor with a more than 90% 5-year mortality. ...
Glioblastoma multiforme (GBM) is the deadliest form of brain tumor with a more than 90% 5-year mortality. ...
Survival Analysis of Glioblastoma Multiforme.
Witthayanuwat S, Pesee M, Supaadirek C, Supakalin N, Thamronganantasakul K, Krusun S. Witthayanuwat S, et al. Asian Pac J Cancer Prev. 2018 Sep 26;19(9):2613-2617. doi: 10.22034/APJCP.2018.19.9.2613. Asian Pac J Cancer Prev. 2018. PMID: 30256068 Free PMC article.
Introduction: To evaluate the survival of Glioblastoma Multiforme (GBM). Material and Methods: Patients with a pathological diagnosis of Glioblastoma Multiforme (GBM) between 1 January 1994 and 30 November 2013, were retrospectively reviewed. ...
Introduction: To evaluate the survival of Glioblastoma Multiforme (GBM). Material and Methods: Patients with a pathological di …
Immune check-point in glioblastoma multiforme.
De Felice F, Pranno N, Marampon F, Musio D, Salducci M, Polimeni A, Tombolini V. De Felice F, et al. Crit Rev Oncol Hematol. 2019 Jun;138:60-69. doi: 10.1016/j.critrevonc.2019.03.019. Epub 2019 Apr 4. Crit Rev Oncol Hematol. 2019. PMID: 31092387 Review.
Glioblastoma multiforme (GBM) represents one of the main frequent and aggressive primary brain neoplasms among adults worldwide. ...
Glioblastoma multiforme (GBM) represents one of the main frequent and aggressive primary brain neoplasms among adults worldwid …
DCVax®-L--developed by Northwest Biotherapeutics.
Polyzoidis S, Ashkan K. Polyzoidis S, et al. Hum Vaccin Immunother. 2014;10(11):3139-45. doi: 10.4161/hv.29276. Hum Vaccin Immunother. 2014. PMID: 25483653 Free PMC article. Review.
Dendritic cell (DC) immunotherapy is emerging as a potential addition to the standard of care in the treatment of glioblastoma multiforme (GBM). In the last decade or so various research groups have conducted phase I and II trials of DC-immunotherapy on patients wit …
Dendritic cell (DC) immunotherapy is emerging as a potential addition to the standard of care in the treatment of glioblastoma mul …
Biomarkers of glioblastoma multiforme.
Nicolaidis S. Nicolaidis S. Metabolism. 2015 Mar;64(3 Suppl 1):S22-7. doi: 10.1016/j.metabol.2014.10.031. Epub 2014 Oct 30. Metabolism. 2015. PMID: 25468141 Review.
Glioblastoma multiforme (GBM) is the most common and lethal primary malignancy of the central nervous system. ...
Glioblastoma multiforme (GBM) is the most common and lethal primary malignancy of the central nervous system. ...
An overview of targets and therapies for glioblastoma multiforme.
Chandrasekar G, Bansal VS, Panigrahi M, Kitambi SS. Chandrasekar G, et al. J Cancer Res Ther. 2022 Apr-Jun;18(3):591-598. doi: 10.4103/jcrt.jcrt_1324_21. J Cancer Res Ther. 2022. PMID: 35900527 Free article. Review.
Glioblastoma multiforme (GBM) affects individuals above 65 years of age and has low median survival rate. ...
Glioblastoma multiforme (GBM) affects individuals above 65 years of age and has low median survival rate. ...
Epigenetic approaches in glioblastoma multiforme and their implication in screening and diagnosis.
Hyman G, Manglik V, Rousch JM, Verma M, Kinkebiel D, Banerjee HN. Hyman G, et al. Methods Mol Biol. 2015;1238:511-21. doi: 10.1007/978-1-4939-1804-1_26. Methods Mol Biol. 2015. PMID: 25421677 Review.
We have summarized information about DNA methylation percentages in Glioblastoma multiforme (GBM) line HTB-12, alveolar cell carcinoma, and acute lymphocytic leukemia samples and determined H3 (K27) methyltransferase activity in GBM and leukemia cells and made compa …
We have summarized information about DNA methylation percentages in Glioblastoma multiforme (GBM) line HTB-12, alveolar cell c …
Circular RNAs and glioblastoma multiforme: focus on molecular mechanisms.
Salami R, Salami M, Mafi A, Vakili O, Asemi Z. Salami R, et al. Cell Commun Signal. 2022 Jan 28;20(1):13. doi: 10.1186/s12964-021-00809-9. Cell Commun Signal. 2022. PMID: 35090496 Free PMC article. Review.
Glioblastoma multiforme (GBM), as a deadly and almost incurable brain cancer, is the most invasive form of CNS tumors that affects both children and adult population. ...
Glioblastoma multiforme (GBM), as a deadly and almost incurable brain cancer, is the most invasive form of CNS tumors that aff …
Imaging glioblastoma multiforme.
Nelson SJ, Cha S. Nelson SJ, et al. Cancer J. 2003 Mar-Apr;9(2):134-45. doi: 10.1097/00130404-200303000-00009. Cancer J. 2003. PMID: 12784879 Review.
Glioblastoma multiforme are infiltrative lesions that have a high degree of heterogeneity, both within and between different patients. ...As the molecular properties that influence invasion and neoplastic transformation are elucidated, it is critical that noninvasiv …
Glioblastoma multiforme are infiltrative lesions that have a high degree of heterogeneity, both within and between different p …
3,389 results